Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (531)
|
Core Tip (583)
|
Full Article (HTML) (2127)
|
Figures (1-1) (397)
|
Full Article (PDF)-1204K (158)
|
Full Article with Cover (PDF)-11949K (152)
|
Full Article (XML)-236K (93)
|
Audio-1342K (6)
|
Peer-Review Report-230K (98)
|
Answering Reviewers-97K (85)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6134)
|
Similar Articles (77)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (576)
|
Core Tip (616)
|
Full Article (HTML) (1497)
|
Tables (1-1) (485)
|
Full Article (PDF)-358K (134)
|
Full Article with Cover (PDF)-11106K (153)
|
Full Article (XML)-54K (89)
|
Audio-1072K (9)
|
Peer-Review Report-236K (82)
|
Answering Reviewers-62K (76)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5077)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (630)
|
Core Tip (523)
|
Full Article (HTML) (5323)
|
Figures (1-2) (427)
|
Tables (1-5) (415)
|
Full Article (PDF)-1655K (244)
|
Full Article with Cover (PDF)-12399K (184)
|
Full Article (XML)-226K (101)
|
Audio-1259K (9)
|
Peer-Review Report-216K (93)
|
Answering Reviewers-145K (88)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (9111)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (633)
|
Core Tip (560)
|
Full Article (HTML) (3384)
|
Figures (1-1) (423)
|
Full Article (PDF)-601K (243)
|
Full Article with Cover (PDF)-11346K (118)
|
Full Article (XML)-89K (98)
|
Audio-384K (5)
|
Peer-Review Report-180K (78)
|
Answering Reviewers-74K (88)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (6827)
|
Similar Articles (335)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (611)
|
Core Tip (548)
|
Article Highlights (571)
|
Full Article (HTML) (2177)
|
Figures (1-4) (377)
|
Tables (1-3) (371)
|
Full Article (PDF)-1672K (142)
|
Full Article with Cover (PDF)-12418K (133)
|
Full Article (XML)-173K (85)
|
Audio-467K (6)
|
Peer-Review Report-182K (74)
|
Answering Reviewers-71K (109)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6812)
|
Similar Articles (2022)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (584)
|
Core Tip (585)
|
Article Highlights (681)
|
Full Article (HTML) (1956)
|
Figures (1-3) (455)
|
Tables (1-2) (410)
|
Full Article (PDF)-1874K (143)
|
Full Article with Cover (PDF)-12619K (135)
|
Full Article (XML)-114K (95)
|
Audio-386K (13)
|
Peer-Review Report-233K (98)
|
Answering Reviewers-161K (89)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7810)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (514)
|
Core Tip (498)
|
Article Highlights (567)
|
Full Article (HTML) (1392)
|
Figures (1-4) (368)
|
Full Article (PDF)-5746K (130)
|
Full Article with Cover (PDF)-16492K (113)
|
Full Article (XML)-96K (91)
|
Audio-3997K (6)
|
Peer-Review Report-192K (80)
|
Answering Reviewers-146K (86)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5417)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (563)
|
Core Tip (546)
|
Article Highlights (586)
|
Full Article (HTML) (2445)
|
Figures (1-4) (366)
|
Tables (1-5) (387)
|
Full Article (PDF)-6006K (166)
|
Full Article with Cover (PDF)-16750K (142)
|
Full Article (XML)-200K (86)
|
Audio-376K (3)
|
Peer-Review Report-182K (94)
|
Answering Reviewers-60K (97)
|
Supplementary Material-355K (96)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8521)
|
Similar Articles (1871)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (522)
|
Core Tip (589)
|
Article Highlights (584)
|
Full Article (HTML) (1651)
|
Figures (1-4) (381)
|
Tables (1-4) (385)
|
Full Article (PDF)-5941K (128)
|
Full Article with Cover (PDF)-16687K (117)
|
Full Article (XML)-115K (86)
|
Audio-187K (9)
|
Peer-Review Report-215K (81)
|
Answering Reviewers-37K (94)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6844)
|
Similar Articles (2486)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (555)
|
Core Tip (553)
|
Full Article (HTML) (1344)
|
Figures (1-1) (453)
|
Full Article (PDF)-5068K (135)
|
Full Article with Cover (PDF)-15813K (113)
|
Full Article (XML)-63K (80)
|
Audio-811K (4)
|
Peer-Review Report-266K (93)
|
Answering Reviewers-225K (93)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5567)
|
Similar Articles (4276)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (551)
|
Core Tip (549)
|
Full Article (HTML) (1369)
|
Full Article (PDF)-325K (115)
|
Full Article with Cover (PDF)-11079K (110)
|
Full Article (XML)-24K (90)
|
Audio-243K (1)
|
Peer-Review Report-215K (65)
|
Answering Reviewers-19K (72)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4004)
|
Similar Articles (394)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open